Parkin

📖 Wiki Page

protein815 wordssynced 2026-04-02

Parkin

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Parkin</th>
</tr>
<tr>
<td class="label">Year</td>
<td>Finding</td>
</tr>
<tr>
<td class="label">1998</td>
<td>PRKN mutations linked to autosomal recessive PD</td>
</tr>
<tr>
<td class="label">2006</td>
<td>PINK1-Parkin pathway identified in mitophagy</td>
</tr>
<tr>
<td class="label">2011</td>
<td>PINK1 phosphorylates Parkin to activate it</td>
</tr>
<tr>
<td class="label">2015</td>
<td>Parkin substrates comprehensively mapped</td>
</tr>
<tr>
<td class="label">2019</td>
<td>Parkin gene therapy shows promise in models</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's" style="color:#ef9a9a">ALZHEIMER'S</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/amyloid" style="color:#ef9a9a">AMYLOID</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2117 edges</a></td>
</tr>
</table>

...

Parkin

Overview

Parkin is an E3 ubiquitin ligase encoded by the [PRKN](/genes/prkn) gene (also known as PARK2) that plays a central role in [mitophagy](/mechanisms/mitophagy) — the selective degradation of damaged mitochondria. Parkin is one of the most significant [Parkinson's disease](/diseases/parkinsons-disease) genes, with autosomal recessive mutations causing early-onset familial PD[@kitada1998].

Parkin is a member of the RBR (RING-in-between-RING) family of E3 ubiquitin ligases. Under basal conditions, Parkin is cytosolic and autoinhibited. Upon mitochondrial damage, Parkin is recruited to the outer mitochondrial membrane where it ubiquitinates numerous substrates, promoting mitochondrial clearance through the autophagy-lysosome pathway[@narendra2010].

Structure and Mechanism

Domain Architecture

Parkin contains multiple functional domains:

N-terminal Ubl domain: Ubiquitin-like domain that keeps Parkin inactive in the cytosol

RING0 domain: Unique to Parkin, contains an inhibitory helix

RING1 domain: Catalytic RING finger that accepts ubiquitin from E2

In-between-RING (IBR) domain: Intermediate domain

RING2 domain: Second catalytic RING finger

Activation Mechanism

Parkin activation follows a carefully regulated sequence:

Phosphorylation: PINK1 phosphorylates both ubiquitin and the Ubl domain of Parkin

Conformational change: Phosphorylation releases autoinhibition, opening the active site

Mitochondrial recruitment: Activated Parkin translocates to damaged mitochondria

Ubiquitination: Parkin ubiquitinates mitochondrial outer membrane proteins

This activation cascade ensures that mitophagy only occurs when mitochondria are genuinely damaged[@kazuhiro2011].

Role in Parkinson's Disease

Genetics

Autosomal recessive inheritance: Biallelic PRKN mutations cause juvenile-onset PD
Over 200 pathogenic variants identified, including missense, nonsense, and copy number variants
Parkin-associated PD typically has earlier onset (before age 40) and slower progression
Heterozygous variants may act as risk factors for late-onset PD[@sarraf2013]

Pathophysiology

Loss of Parkin function leads to:

Accumulation of damaged mitochondria: Failure to clear dysfunctional mitochondria

Increased oxidative stress: Damaged mitochondria produce excess ROS

Energy deficit: Impaired mitochondrial function reduces ATP production

Neuronal death: Particularly affecting [dopaminergic neurons](/dopaminergic-neurons) in the substantia nigra

Mitophagy Pathway

PINK1-Parkin Pathway

The canonical mitophagy pathway proceeds as follows:

Mitochondrial damage: Occurs via cellular stress, toxins, or mutations

PINK1 stabilization: On damaged mitochondria, PINK1 accumulates on the outer membrane

PINK1 activation: Activated PINK1 phosphorylates ubiquitin and Parkin

Parkin recruitment: Phospho-Parkin translocates to mitochondria

Substrate ubiquitination: Parkin ubiquitinates mitochondrial proteins

Autophagy receptor recruitment: p62/SQSTM1, OPTN, NDP52 bind ubiquitin chains

Phagosome formation: LC3-positive autophagosome engulfs the mitochondrion

Lysosomal degradation: Fusion with lysosome completes mitophagy

Substrate Specificity

Parkin ubiquitinates numerous mitochondrial substrates:

Mitofusins (MFN1, MFN2): Fusion proteins, their ubiquitination prevents re-fusion
VDAC1: Voltage-dependent anion channel
TOMM20: Translocase of outer membrane
MIRO1: Mitochondrial Rho GTPase
HK2: Hexokinase II, linking metabolism to mitophagy

Parkin and Other Neurodegenerative Diseases

Alzheimer's Disease

While primarily a PD gene, Parkin may play roles in AD:

Altered Parkin expression found in AD brain
Parkin can degrade amyloid precursor protein (APP) fragments
May affect tau phosphorylation through ubiquitin-dependent pathways[@burns2005]

Amyotrophic Lateral Sclerosis

Parkin dysfunction has been reported in ALS:

Mutations in PARKIN associated with some ALS cases
Parkin loss may contribute to mitochondrial dysfunction in motor neurons

Huntington's Disease

Parkin compensates for mutant huntingtin:

Parkin overexpression reduces polyglutamine toxicity
Parkin-mediated mitophagy helps clear damaged mitochondria in HD models

Therapeutic Strategies

Gene Therapy

AAV-PARKIN delivery: Viral vector-mediated PARKN gene expression
PRKN promoter optimization: Enhancing expression in dopaminergic neurons
Current trials exploring safety and efficacy in PD patients[@chaturvedi2019]

Small Molecule Activators

Parkin activators: Compounds that promote Parkin activation
PINK1 activators: Upstream pathway enhancement
Ubiquitin replacement: Enhancing general ubiquitination

Mitochondrial Protection

Antioxidants: Reducing oxidative stress on mitochondria
Mitochondrial biogenesis promoters: PGC-1α activators
Mitochondrial dynamics modulators: Fusion/fission balancers

Key Research Findings

Cross-References

[PRKN Gene](/genes/prkn) - Genetic overview
[PINK1](/genes/pink1) - Partner kinase in mitophagy
[Parkinson's Disease](/diseases/parkinsons-disease) - Associated disease
[Mitophagy](/mechanisms/mitophagy) - Pathway overview
[Dopaminergic Neurons](/dopaminergic-neurons) - Affected cell type
[Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction) - Related mechanism

Pathway & Interaction Diagram

Interactive diagram showing PARKIN's key relationships in the SciDEX knowledge graph (15 connections shown).

Mermaid diagram (expand to render)

External Links

[GeneCards: PRKN](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRKN)

References

[Kitada T, et al, Mutations in the parkin gene cause autosomal recessive Parkinson's disease (1998)](https://pubmed.ncbi.nlm.nih.gov/9513748/)

[Narendra DP, et al, PINK1 is selectively stabilized on impaired mitochondria to activate Parkin (2010)](https://pubmed.ncbi.nlm.nih.gov/20075042/)

[Kazuhiro K, et al, PINK1 activates Parkin through direct phosphorylation (2011)](https://pubmed.ncbi.nlm.nih.gov/21264345/)

[Sarraf SA, et al, Global landscape and dynamics of Parkin substrates (2013)](https://pubmed.ncbi.nlm.nih.gov/23619963/)

[Burns MP, et al, Parkin expression in Alzheimer's disease (2005)](https://pubmed.ncbi.nlm.nih.gov/15590652/)

[Chaturvedi RK, et al, Adeno-associated virus-mediated Parkin delivery in animal models (2019)](https://pubmed.ncbi.nlm.nih.gov/30766912/)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Microbial Inflammasome Priming Prevention](/hypothesis/h-e7e1f943) — 0.76 · Target: NLRP3, CASP1, IL1B, PYCARD
[Targeted Butyrate Supplementation for Microglial Phenotype Modulation](/hypothesis/h-3d545f4e) — 0.72 · Target: GPR109A
[Vagal Afferent Microbial Signal Modulation](/hypothesis/h-ee1df336) — 0.71 · Target: GLP1R, BDNF
[Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming](/hypothesis/h-f3fb3b91) — 0.67 · Target: TLR4
[Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain Anti-Inflammatory Communication](/hypothesis/h-a4e259e0) — 0.65 · Target: CHRNA7
[Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding](/hypothesis/h-8b7727c1) — 0.64 · Target: CSGA
[Gut Barrier Permeability-α-Synuclein Axis Modulation](/hypothesis/h-6c83282d) — 0.60 · Target: CLDN1, OCLN, ZO1, MLCK
[Microbial Metabolite-Mediated α-Synuclein Disaggregation](/hypothesis/h-74777459) — 0.57 · Target: SNCA, HSPA1A, DNMT1

Related Analyses:

[What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesi](/analysis/SDA-2026-04-01-gap-20260401-225149) 🔄
[What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesi](/analysis/SDA-2026-04-01-gap-20260401-225155) 🔄

Pathway Diagram

The following diagram shows the key molecular relationships involving Parkin discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Parkin

Parkin

Overview

Parkin

Overview

Structure and Mechanism

Domain Architecture

Activation Mechanism

Role in Parkinson's Disease

Genetics

Pathophysiology

Mitophagy Pathway

PINK1-Parkin Pathway

Substrate Specificity

Parkin and Other Neurodegenerative Diseases

Alzheimer's Disease

Amyotrophic Lateral Sclerosis

Huntington's Disease

Therapeutic Strategies

Gene Therapy

Small Molecule Activators

Mitochondrial Protection

Key Research Findings

Cross-References

Pathway & Interaction Diagram

See Also

External Links

References

Related Hypotheses

Pathway Diagram